헬스케어 스마트 라벨 : 시장 점유율 분석, 업계 동향 및 통계, 성장 예측(2026-2031년)

According to Mordor Intelligence, the healthcare smart labels market size is projected to expand from USD 3.76 billion in 2025 and USD 4.28 billion in 2026 to USD 7.21 billion by 2031, registering a CAGR of 13.92% between 2026 to 2031.

This report is Segmented by Technology (RFID Labels, NFC (High Frequency) Tags, and More), Component (Batteries, Microprocessors / ICs, Transceivers, Sensors and Memory), Application (Drug Tracking & Serialization, Cold-Chain Monitoring, and More), End User (Hospitals, Pharmaceutical Companies, and More), and Geography (North America, Europe, and More). The Market and Forecasted in Terms of Value (USD).

Global Healthcare Smart Labels Market Trends and Insights

DSCSA/EU FMD Serialization Mandates Accelerate Item-Level Labeling

Serialization requirements in the United States and Europe continue to lift demand for item-level labeling, with DSCSA emphasizing interoperable, electronic tracing and the EU FMD relying on pack-level verification through EMVS. The DSCSA enhanced distribution security framework requires trading partners to exchange serialized data and investigate suspect products, which encourages pharmaceutical manufacturers and distributors to standardize barcodes and RFID-based identifiers on unit packages and cases. In the EU, the FMD architecture implements unique identifiers and anti-tamper devices on prescription medicines, making machine-readable 2D DataMatrix labels a default for verification at dispensing points, including hospital pharmacies. These requirements create a durable baseline for the healthcare smart labels market as companies refresh and expand labeling systems to remain compliant. The operational push for interoperable data also aligns with EPCIS-based exchange, which in turn favors serialized barcodes and RAIN RFID that integrate smoothly with enterprise systems.

Anti-Counterfeiting and Diversion Control Priorities in Pharma

Pharmaceutical stakeholders use smart labels to deter counterfeiting, detect diversion, and enable rapid recalls, with serialization and tamper-evidence working alongside mobile verification. Health authorities continue to warn that falsified medical products remain a threat, reinforcing the need for secure, scannable labels on each saleable unit as well as on secondary packaging. Item-level barcodes and NFC tags support authentication and chain-of-custody checks across wholesalers, third-party logistics providers, and hospital pharmacies. In parallel, RFID enables automated counting and location tracking in warehouses and care settings, which helps reduce shrinkage and detect anomalies in high-value therapies. These capabilities together strengthen the healthcare smart labels market by reducing error and risk exposure across the regulated supply chain.

High Implementation and Infrastructure Cost Across Labels/Readers/Software

Total cost of ownership includes labels and inlays, readers and printers, encoding and verification stations, and the software needed to capture and exchange EPCIS events. Hospitals and pharma distribution sites must budget for systems integration and process changes, including staff training and change management to ensure compliance. Passive RFID systems can lower costs over time, but upfront investment in readers and infrastructure remains a barrier, especially for smaller facilities. Active BLE tags that incorporate batteries or advanced sensors carry higher unit costs, which narrows the range of use cases where ROI is immediately clear. These economic factors can delay some deployments in the healthcare smart labels market, particularly where the value density of products is moderate.

Other drivers and restraints analyzed in the detailed report include:

1. Expansion of Biologics/Vaccines Cold-Chain Needs Temperature-Indicating Labels
2. Healthcare Digitalization and RFID/NFC Adoption in Hospitals and Pharma
3. Data Privacy, Security, and Interoperability Hurdles (HIPAA/GDPR/EPCIS)

For complete list of drivers and restraints, kindly check the Table Of Contents.

Segment Analysis

In 2025, QR Code and 2D DataMatrix labels led with 41.23% of the healthcare smart labels market share in technology, reflecting their central role in DSCSA and EMVS verification at the unit level in hospitals and pharmacies. Over 2026-2031, sensing labels that capture temperature and related conditions are projected to grow fastest at a 14.65% CAGR as biologics and vaccines expand, and stakeholders seek simple unit-level condition visibility across cold-chain movements. RAIN RFID continues to scale for automated counting and cabinet management in care settings, while NFC complements with patient-initiated taps for authentication and information access. EAS overlaps where item security is required in retail and hospital pharmacy settings that handle specialty therapies. Multi-technology strategies remain common, so clinical and logistics teams can scan 2D barcodes while inventory teams automate with RFID, preserving resilience in the healthcare smart labels market.

As data standards evolve, EPCIS 2.0 enables combined serialization and sensor events that increase the return from sensor labels and RFID deployments in regulated workflows. This integration makes sensing more attractive since condition data can be natively associated with unique identifiers and exchanged across trading partners. Hospital RTLS deployments that leverage BLE are complementary to RFID and barcodes, broadening visibility beyond fixed choke points. In this context, technology choices align with use-case priorities such as bedside verification, automated counting, or unit-level cold-chain assurance in the healthcare smart labels industry. The combined trajectory supports a balanced mix in which low-cost 2D barcodes remain ubiquitous while sensing and RFID gain share in high-impact applications of the healthcare smart labels market.

Microprocessors and ICs accounted for 42.96% of the component stack in 2025, reflecting their presence across RFID, NFC, and advanced sensor tag designs that drive value capture in the supply chain. Sensors are projected to grow at a 14.82% CAGR during 2026-2031 as cold-chain expansion, specialty therapy handling, and clinical telemetry use cases scale across manufacturing, distribution, and care delivery. Memory and transceivers remain essential enablers of reliable reads and data retention across temperature excursions and challenging RF environments. Batteries appear in active BLE and specialty labels where continuous broadcasting or condition logging is required, although energy-harvesting trends reduce the need for battery replacements over time. These component trends favor a durable shift toward condition-aware labeling in the healthcare smart labels market.

As EPCIS 2.0 supports sensor events, more solutions pair sensors with serialization data, which increases integration value without requiring custom data models. Hospitals and pharma distribution centers benefit when components enable labels that are reliable on metals and liquids, which depend on IC sensitivity, tuned antennas, and calibrated sensor elements. Vendors that optimize component stacks for small vials and curved surfaces unlock new footprints where conventional tags struggled. These advances reinforce the trajectory for sensors and high-performance ICs in the healthcare smart labels industry while the healthcare smart labels market attracts more solution diversity.

Geography Analysis

North America accounted for 43.14% in 2025, supported by DSCSA-driven serialization, hospital digitalization, and strong adoption of RFID and BLE infrastructure across care settings. Asia-Pacific is projected to grow at a 14.76% CAGR during 2026-2031 as regional healthcare systems scale hospital automation, expand biologics manufacturing, and adopt serialization in line with global trading partner expectations. Europe maintains robust demand through EMVS verification and hospital workflows that operationalize 2D barcode scanning with selective RFID adoption in clinical logistics. These regional demand patterns sustain the healthcare smart labels market as standards and infrastructure investments converge.

In North America, the United States sets the pace with DSCSA interoperability requirements and hospital investments in RFID-enabled cabinets and inventory systems, while Canada and Mexico raise digital readiness in hospital and distribution operations. In Europe, Germany, the United Kingdom, France, Italy, and Spain drive consistent pack-level verification and warehouse scanning for compliance and supply assurance. The rest of Europe expands as hospitals refresh scanning and verification equipment, and as specialty therapies grow in volume and value.

Across Asia-Pacific, China scales serialization and healthcare logistics technology, India deepens pharma manufacturing and CDMO capabilities, and Japan, Australia, and South Korea maintain high digital maturity in hospital operations. The Rest of Asia-Pacific introduces blended RFID and barcode workflows, often starting with high-value products and cold-chain shipments. In the Middle East and Africa, GCC markets lead with hospital modernization and specialty imports that require compliant labeling, while South Africa progresses with pharmacy and hospital traceability investments. In South America, Brazil and Argentina expand specialty distribution and hospital barcode verification, while returns processing and cold-chain management lift interest in condition-aware labels. These trends collectively sustain diversified growth in the healthcare smart labels market across regions.

1. Alien Technology LLC
2. AVERY DENNISON
3. Beontag
4. Brady Corporation
5. CCL Industries Inc.
6. Checkpoint Systems
7. HID Global (GuardRFID)
8. Identiv Inc.
9. Impinj Inc.
10. Invengo Information Technology Co. Ltd.
11. NXP Semiconductors
12. SATO Holdings Corporation
13. Schreiner MediPharm
14. SpotSee
15. Stora Enso Intelligent Packaging
16. Tageos
17. Timestrip UK Ltd.
18. TSC Printronix Auto ID
19. Wiliot
20. Zebra Technologies

Additional Benefits:

• The market estimate (ME) sheet in Excel format
• 3 months of analyst support

TABLE OF CONTENTS

1 Introduction

• 1.1 Study Assumptions & Market Definition
• 1.2 Scope of the Study

2 Research Methodology

3 Executive Summary

4 Market Landscape

• 4.1 Market Overview
• 4.2 Market Drivers
  • 4.2.1 DSCSA/EU FMD Serialization Mandates Accelerate Item-Level Labeling
  • 4.2.2 Anti-Counterfeiting and Diversion Control Priorities in Pharma
  • 4.2.3 Expansion of Biologics/Vaccines Cold-Chain Needs Temperature-Indicating Labels
  • 4.2.4 Healthcare Digitalization and RFID/NFC Adoption in Hospitals and Pharma
  • 4.2.5 EPCIS 2.0 and Interoperable Data Exchange Enable Sensorized Smart Labels
  • 4.2.6 Ambient IoT/BLE Sensing Brings Unit-Level Condition Visibility
• 4.3 Market Restraints
  • 4.3.1 High Implementation and Infrastructure Cost Across Labels/Readers/Software
  • 4.3.2 Data Privacy, Security, and Interoperability Hurdles (HIPAA/GDPR/EPCIS)
  • 4.3.3 RFID Performance Challenges on Vials/Liquids/Metal-Rich Environments
  • 4.3.4 Fragmented Standards and Compliance Workflows Across DSCSA/UDI/EMVS
• 4.4 Value / Supply-Chain Analysis
• 4.5 Regulatory Landscape
• 4.6 Technological Outlook
• 4.7 Porters Five Forces Analysis
  • 4.7.1 Threat of New Entrants
  • 4.7.2 Bargaining Power of Buyers
  • 4.7.3 Bargaining Power of Suppliers
  • 4.7.4 Threat of Substitutes
  • 4.7.5 Competitive Rivalry

5 Market Size & Growth Forecasts (Value, USD)

• 5.1 By Technology
  • 5.1.1 RFID Labels (RAIN UHF)
  • 5.1.2 NFC (High Frequency) Tags
  • 5.1.3 Sensing Labels
  • 5.1.4 Electronic Article Surveillance (EAS)
  • 5.1.5 QR Code / 2D Barcode Labels (DataMatrix, QR)
• 5.2 By Component
  • 5.2.1 Batteries
  • 5.2.2 Microprocessors / ICs
  • 5.2.3 Transceivers
  • 5.2.4 Sensors
  • 5.2.5 Memory
• 5.3 By Application
  • 5.3.1 Drug Tracking & Serialization
  • 5.3.2 Cold-chain Monitoring
  • 5.3.3 Medical Equipment Tracking
  • 5.3.4 Patient Identification & Safety
  • 5.3.5 Laboratory Sample Tracking
• 5.4 By End User
  • 5.4.1 Hospitals
  • 5.4.2 Pharmaceutical Companies
  • 5.4.3 Diagnostic Laboratories
  • 5.4.4 Pharmacies & Retail Pharmacies
  • 5.4.5 Contract Manufacturers (CMOs/CDMOs)
• 5.5 By Geography
  • 5.5.1 North America
    • 5.5.1.1 United States
    • 5.5.1.2 Canada
    • 5.5.1.3 Mexico
  • 5.5.2 Europe
    • 5.5.2.1 Germany
    • 5.5.2.2 United Kingdom
    • 5.5.2.3 France
    • 5.5.2.4 Italy
    • 5.5.2.5 Spain
    • 5.5.2.6 Rest of Europe
  • 5.5.3 Asia-Pacific
    • 5.5.3.1 China
    • 5.5.3.2 India
    • 5.5.3.3 Japan
    • 5.5.3.4 Australia
    • 5.5.3.5 South Korea
    • 5.5.3.6 Rest of Asia-Pacific
  • 5.5.4 Middle East and Africa
    • 5.5.4.1 GCC
    • 5.5.4.2 South Africa
    • 5.5.4.3 Rest of Middle East and Africa
  • 5.5.5 South America
    • 5.5.5.1 Brazil
    • 5.5.5.2 Argentina
    • 5.5.5.3 Rest of South America

6 Competitive Landscape

• 6.1 Market Concentration
• 6.2 Market Share Analysis
• 6.3 Company Profiles (includes Global level Overview, Market level overview, Core Segments, Financials as available, Strategic Information, Market Rank/Share for key companies, Products & Services, and Recent Developments)
  • 6.3.1 Alien Technology LLC
  • 6.3.2 Avery Dennison Corporation
  • 6.3.3 Beontag
  • 6.3.4 Brady Corporation
  • 6.3.5 CCL Industries Inc.
  • 6.3.6 Checkpoint Systems
  • 6.3.7 HID Global (GuardRFID)
  • 6.3.8 Identiv Inc.
  • 6.3.9 Impinj Inc.
  • 6.3.10 Invengo Information Technology Co. Ltd.
  • 6.3.11 NXP Semiconductors
  • 6.3.12 SATO Holdings Corporation
  • 6.3.13 Schreiner MediPharm
  • 6.3.14 SpotSee
  • 6.3.15 Stora Enso Intelligent Packaging
  • 6.3.16 Tageos
  • 6.3.17 Timestrip UK Ltd.
  • 6.3.18 TSC Printronix Auto ID
  • 6.3.19 Wiliot
  • 6.3.20 Zebra Technologies Corporation

7 Market Opportunities & Future Outlook

• 7.1 White-space & Unmet-need Assessment